Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using ibutilide to convert atrial fibrillation and flutter.

D A Sargent1

  • 1dsarg4525@aol.com

Dimensions of Critical Care Nursing : DCCN
|January 20, 2000
PubMed
Summary

Ibutilide fumarate injection is the first FDA-approved antiarrhythmic for acute conversion of recent-onset atrial fibrillation and flutter. It is particularly useful in critical care and emergency settings for nurses managing patients and adverse events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why Women Get so Short of Breath.

Hall's journal of health·2022
Same author

"STRENGTH TESTS AND THE STRONG MEN OF HARVARD."

Journal. Boston Society of Medical Sciences·2009
Same author

ON THE RELATION OF THE CEPHALIC INDEX TO HEIGHT, WEIGHT, STRENGTH, AND MENTAL ABILITY.

Journal. Boston Society of Medical Sciences·2009
Same author

A Fundamental Mechanism for a New System of Motor Vehicles, Testing Apparatus, and Developing Appliances.

Journal. Boston Society of Medical Sciences·2009
Same author

Physical Training.

Public health papers and reports·2009
Same author

Report of Committee on School Hygiene.

Public health papers and reports·2009

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Atrial fibrillation and flutter are common arrhythmias requiring effective treatment.
  • The development of novel antiarrhythmic agents is crucial for improving patient outcomes.

Observation:

  • Ibutilide fumarate injection represents a significant advancement as the first FDA-approved drug for acute conversion of recent-onset atrial fibrillation/flutter.
  • Its primary application is anticipated in critical care units and emergency departments.

Findings:

  • The drug facilitates rapid conversion of atrial arrhythmias.
  • Clinical monitoring by critical care nurses is essential for managing potential adverse events.

Implications:

  • This medication offers a new therapeutic option for emergency and critical care physicians.

Related Experiment Videos

  • Advanced practice nurses play a vital role in patient education and staff training regarding ibutilide fumarate use.
  • Effective management of atrial fibrillation and flutter can reduce the risk of complications such as stroke.